title: [The effect of ingavirin on the ultrastructural properties of morphogenesis of parainfluenza in vitro and in vivo].
authors.forename: V V
authors.initials: VV
authors.lastname: Zarubaeva
authors.forename: A V
authors.initials: AV
authors.lastname: Garshinina
authors.forename: N A
authors.initials: NA
authors.lastname: Kalinina
authors.forename: S V
authors.initials: SV
authors.lastname: Beliaeskaia
authors.forename: A K
authors.initials: AK
authors.lastname: Sirotkin
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
authors.forename: O I
authors.initials: OI
authors.lastname: Kuselev
authors.forename: D V
authors.initials: DV
authors.lastname: Reĭkhart
mesh_terms: D000577:Amides / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D002208:Caproates; D002460:Cell Line; D006224:Cricetinae; D003998:Dicarboxylic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D004195:Disease Models, Animal; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008647:Mesocricetus; D009024:Morphogenesis; D018184:Paramyxoviridae Infections / Q000188:drug therapy* / Q000821:virology; D011024:Pneumonia, Viral / Q000188:drug therapy / Q000473:pathology; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D012254:Ribavirin / Q000627:therapeutic use; D014771:Virion / Q000187:drug effects / Q000472:pathogenicity
chemical_list: D000577:Amides; D000998:Antiviral Agents; D002208:Caproates; D003998:Dicarboxylic Acids; D007093:Imidazoles; C539419:pentanedioic acid imidazolyl ethanamide; D012254:Ribavirin